The Cartiva Implant скачать в хорошем качестве

The Cartiva Implant

The Cartiva Implant, also known as Cartiva Synthetic Cartilage Implant (SCI), is a medical device used primarily in the treatment of osteoarthritis of the big toe, a condition known as hallux rigidus. Here's an overview: Purpose Treatment of Hallux Rigidus: The Cartiva Implant is designed to relieve pain and improve function in patients suffering from arthritis in the big toe joint. Design Material: The implant is made from polyvinyl alcohol (PVA) hydrogel, a biocompatible material that mimics the properties of natural cartilage. Structure: It has a porous structure, allowing tissue ingrowth, which helps to anchor it in place within the bone. Procedure Implantation: The implant is inserted into the metatarsophalangeal (MTP) joint of the big toe. This is done through a minimally invasive surgical procedure. Bone Preparation: A small hole is drilled into the metatarsal head, where the implant is placed to act as a cartilage replacement. Benefits Pain Relief: Reduces pain associated with arthritis in the big toe. Range of Motion: Preserves and may even improve the range of motion of the joint compared to traditional treatments like joint fusion. Minimally Invasive: The procedure is less invasive than traditional joint fusion surgeries, leading to quicker recovery times. Alternatives Conservative Treatments: Orthotics, physical therapy, pain medications. Surgical Alternatives: Joint fusion (arthrodesis), joint replacement (arthroplasty), cheilectomy (removal of bone spurs). Outcomes Success Rate: Studies have shown positive outcomes in terms of pain relief and function, with many patients experiencing significant improvements. Longevity: While the Cartiva Implant provides a promising alternative to joint fusion, long-term studies are ongoing to fully understand its durability and long-term benefits. Considerations Suitability: Not all patients are candidates for the Cartiva Implant. Factors such as the severity of arthritis, bone quality, and patient activity levels are considered. Potential Complications:** As with any surgical procedure, there are risks, including infection, implant displacement, or continued pain. Regulatory Status FDA Approval: The Cartiva SCI received FDA approval in 2016, indicating it has been evaluated for safety and efficacy in the treatment of hallux rigidus. The Cartiva Implant represents a significant advancement in the treatment of hallux rigidus, offering an alternative that maintains joint mobility and has a quicker recovery time compared to traditional fusion surgeries. #cartiva #implant #medical #animation #surgery #procedure #video #biology